Additionally, activation of the MAPKs (JNK) and NF-κB signaling aggravate the underlying condition, while attenuation of NF-κB and MAPKs (JNK) reduce the signs and symptoms associated with rheumatoid arthritis [57]. The gene discussed is NFKB1; the disease is rheumatoid arthritis.